"Designing Growth Strategies is in our DNA"

Laboratory Informatics Market Size, Share & Industry Analysis, By Component (Software & Services), By Product (Laboratory Information Management Systems (LIMS), Electronic Lab Notebooks (ELN), Scientific Data Management Systems (SDMS), Laboratory Execution Systems (LES), & Enterprise Content Management (ECM)), By Deployment (Cloud-based, Web-based, and On-premise), By Application (R&D and Experiment Documentation, Quality Assurance/Compliance, and Clinical Trial Data & Patient Data Management), By End User (Pharmaceutical & Biotech Industries), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI114259

 

Laboratory Informatics Market Size and Future Outlook

Play Audio Listen to Audio Version

The global laboratory informatics market size was valued at USD 4.11 billion in 2024. The market is projected to grow from USD 4.29 billion in 2025 to USD 7.19 billion by 2032, exhibiting a CAGR of 7.64% during the forecast period. North america dominated the laboratory informatics market with a market share of 49.14% in 2024.

Laboratory informatics is based on information technology for the management and optimization of laboratory data, workflows, and operations. It involves use of software and different systems for the improvisation of data accuracy, ensuring compliance, and streamlining processes in various settings. Prominent factors such as growing adoption of automation & digital transformation, and integration of AI, machine learning & analytics, and others are supporting the upward trajectory of the market.

Furthermore, the market encompasses several major players such as Thermo Fisher Scientific Inc., LabVantage Solutions Inc., and LabWare, among others. A wide range of product portfolio coupled with strong geographic expansion have supported the dominance of these companies in the global market.

MARKET DYNAMICS

MARKET DRIVERS:

Growing Adoption of Automation & Digital Transformation to Drive Market Growth

One of the prominent growth drivers in the laboratory informatics industry is the growing adoption of automation & digital transformation. The increasing number of laboratories are shifting toward fully automated and paperless workflows instead of traditional, manual, and paper-based processes. This transformation has reduced human errors along with improvements in efficiency, accuracy, and turnaround time. This has especially enhanced operations in data-intensive works such as drug discovery, genomics, and clinical testing. The integration of laboratory informatics platforms with instruments, robotics, and AI-based tools allows seamless data capture, analysis, and reporting. This in turn enhances productivity and regulatory compliance.

  • For instance, in September 2024, CloudLIMS, integrated its cannabis LIMS with Metrc, the state-mandated seed-to-sale tracking system in Rhode Island, U.S.

MARKET RESTRAINTS:

High Implementation & Maintenance Costs to Restrict Market Expansion

One of the major restraints in the global laboratory informatics market is the high cost of implementation and maintenance. This factor significantly impacts the adoption of these products and services by small and mid-sized laboratories. The integration of advanced solutions such as LIMS, ELN, or SDMS usually requires substantial upfront investment in hardware, software, customization, and validation. In addition, ongoing expenses related to training, upgrades, technical support, and periodic maintenance further increase the total cost. This financial burden often prevents smaller organizations, research labs, and labs in emerging economies from adopting these systems, despite their long-term efficiency benefits.

  • For example, according to the data published by 1LIMS, a company operating in this market, the cost of LIMS software typically ranges from USD 10,000 to USD 200,000.

MARKET OPPORTUNITIES:

Integration of Artificial Intelligence to Create Lucrative Growth Opportunities

The integration of artificial intelligence is anticipated to create promising growth opportunities in the market. Advanced analytics and AI-driven informatics platforms can transform raw lab data into predictive insights, supporting drug discovery, clinical decision-making, and quality assurance. This presents a strong opportunity for vendors offering AI-enabled tools. This enhances research productivity along with reducing the cost and time required for bringing new therapies to market.

LABORATORY INFORMATICS MARKET TRENDS:

Adoption of Cloud-Based & SaaS Solutions is a Significant Market Trends

The rapid adoption of cloud-based and SaaS (software-as-a-service) solutions is one of the key trends in the market. Cloud and software-as-a-service delivery reduce infrastructure cost, enable remote access, and simplify updates and scalability, boosting adoption especially in newer laboratories. Laboratories are increasingly shifting away from on-premise deployments toward cloud-hosted platforms due to their several advantages including scalability, flexibility, and lower upfront costs. Moreover, cloud systems enhance data security, compliance, and integration with other digital tools, making them a preferred choice.

  • For instance, in August 2021, LabVantage Solutions Inc. introduced LabVantage Enterprise SaaS in the market.

MARKET CHALLENGES:

Complex Integration of with Traditional Systems to Hamper Market Growth

A key challenge in the global market is the complex integration of new systems with already present infrastructure. Several laboratories, particularly in pharmaceuticals and academic research, still rely on fragmented IT setups, traditional instruments, or paper-based workflows. Thus, migrating or replacing them is costly and disruptive, which results in slower product adoption. Furthermore, mismatched data formats and the lack of standardized protocols across labs make the integration process technically complex, in turn challenging the global laboratory informatics market growth.

  • For instance, various pharmaceutical companies such as Novartis AG have described challenges in upgrading their ELN system and integrating it with existing infrastructure.

Download Free sample to learn more about this report.

Segmentation Analysis

By Product

High Adoption of Laboratory Information Management Systems (LIMS) Contributed to Segment Growth

On the basis of the product, the market is classified into laboratory information management systems (LIMS), electronic lab notebooks (ELN), scientific data management systems (SDMS), laboratory execution systems (LES), enterprise content management (ECM), and others.

The laboratory information management systems (LIMS) segment accounted for the largest global laboratory informatics market share in 2024. The increasing adoption of these systems owing to its wide range of functions, important role in workflow management, and other factors has primarily driven the segment growth. In addition, LIMS platforms help laboratories comply with strict regulatory frameworks such as FDA EMA, HIPAA, and GLP/GMP. Its ability to generate audit trails, electronic signatures, and traceability records positions it as the primary informatics tool in regulated industries. Additionally, increasing new product launches also supplements the segment growth.

  • For instance, in June 2025, APHA Scientific launched PT-LIMS, a new laboratory information management system for all registered customers.

To know how our report can help streamline your business, Speak to Analyst

By Component

Growing Shift toward Outsourcing Contributed to Segmental Growth

On the basis of component, the market is segmented into individual software and services.

The services segment captured the dominating share of the market in 2024. The increasing shift toward outsourcing of laboratory informatics, and rising adoption of cloud-based LIMS and ELNs have majorly driven the segment growth. Moreover, presence of well-established companies in offering these services also supplements the segment growth.

  • For instance, IDBS is one of the leading service providers in this segment.

The software segment is expected to grow at a CAGR of 6.65% over the study period. 

By Deployment

Advantages Offered by Capsules Supplemented Segmental Growth

In terms of deployment, the market is divided into cloud-based, web-based, and on-premise.

The on-premise segment held the leading share of the market in 2024. This can be attributed to the strict compliance with regulations and preferred in-house control over sensitive data by key end users such as pharmaceutical companies. On-premise systems also offered greater customization, direct security control, and integration with legacy instruments. Owing to these factors, the segment dominated the overall market.

  • For instance, LabVantage, STARLIMS Corporation, and Thermo Fisher Scientific Inc. are some of the leading companies that extensively offer on-premise lab informatics.

The cloud-based segment is expected to grow at a CAGR of 11.73% over the forecast years. 

By Application

Increasing Focus on Research Fuels Segmental Growth

In terms of application, the market is categorized into R&D and experiment documentation, quality assurance/compliance, clinical trial data & patient data management, and others.

The R&D and experiment documentation segment is anticipated to dominate the market over the forecast period. Heavy influx of investment for research and development activities by pharmaceutical and biotechnology companies, and increasing demand for advanced solutions to capture, organize, and analyze experimental results have contributed to the dominance of the segment. Additionally, the growing focus on data integrity and innovation is also fueling demand for products in this application.

  • For instance, Lab Informatics is one of the leading players offering these products.

The quality assurance/compliance segment is expected to witness 6.76% growth over the forecast period.

By End User

High Investments in R&D by Pharmaceutical & Biotechnology Industries Propelled Segment Growth

Based on end user, the market is segmented into pharmaceutical & biotechnology industries, CROs & CDMOs, and others.

In terms of end user, in 2024 pharmaceutical & biotechnology industries held the dominating share of the global market. This owing to their increasing investments in research & development, rising adoption of advanced products for data management, and strong reliance on lab informatics solutions. Furthermore, the segment is set to hold a market share of 59.7% share in 2025.

In addition, the CROs & CDMOs segment is projected to grow at a CAGR of 11.07% during the forecast period.

Laboratory Informatics Market Regional Outlook

By region, the market is divided into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.

North America

North America captured the dominating share of the global market in 2023 valuing at USD 2.00 billion and also took the leading share in 2024 with USD 2.02 billion. The dominance of the region can be attributed to the factors such high demand for cloud-based solutions, active involvement in innovative drug development by pharmaceutical companies, and advanced healthcare infrastructure. In 2025, the U.S. market is estimated to reach USD 1.91 billion. The country’s market growth is driven by increased R&D, the need for data management and regulatory compliance, and the adoption of cloud-based and AI-integrated systems.

  • For instance, according to the data published by scimcon in June 2024, LIMS integration was the topmost investment priority for the around 17% of the SmartLab Exchange event attendees.

North America Laboratory Informatics Market Size, 2019-2032 (USD Billion)

To get more information on the regional analysis of this market, Download Free sample

Europe and Asia Pacific

On the other hand, markets in the Europe and Asia Pacific regions are anticipated to witness a notable growth rate over the study period. During the forecast period, the European region is anticipated to grow at a CAGR of 7.75%, which is the second largest region amongst all the regions and touch the valuation of USD 0.92 billion in 2025. Key factors responsible for this include increasing data from research, advanced healthcare infrastructures, along with a rising number of strategic collaborations in the region. Backed by these factors, countries including the U.K. anticipate to record the valuation of USD 0.19 billion, Germany to record USD 0.22 billion, and France to record USD 0.17 billion in 2025. After Europe, the market in Asia Pacific is valued to reach USD 0.87 billion in 2025 and secure the position of third-largest region in the market. In the region, India and China both are estimated to reach USD 0.17 billion and USD 0.22 billion respectively in 2025.

Latin America and Middle East & Africa

Furthermore, the Latin America laboratory informatics market and the Middle East & Africa market are anticipated to witness a slower growth over the study period. The Latin America market in 2025 is set to record USD 0.20 billion as its valuation. Advancement in healthcare infrastructure is anticipated to drive the adoption of these products in these regions in the coming years. In the Middle East & Africa, GCC is set to attain the value of USD 0.09 billion in 2025.

COMPETITIVE LANDSCAPE

Key Industry Players:

Availability of Broad Product Portfolio coupled with Strong Geographical Presence of Leading Companies Supported their Dominating Position

The global market is moderately consolidated, with a mix of well-established players and specialized regional players. Leading companies such as Thermo Fisher Scientific, LabWare, and LabVantage Solutions dominate the market. This dominance can be attributed to their broad product portfolios, and strong global presence across various industries. Their strong integration capabilities, strategic collaborations with research institutions, and cloud-enabled offerings further strengthen their leadership positions.

  • For instance, in March 2024, Thermo Fisher Scientific introduced enhanced features in its SampleManager LIMS software, integrating advanced analytics and AI-driven data visualization tools to improve lab productivity and compliance management.

Other key players include Dassault Systèmes, Core Informatics, and LabLynx. These companies are actively focusing on innovative product launches, and integration of AI and machine learning, and cloud-based deployments to expand their market presence.

LIST OF KEY LABORATORY INFORMATICS COMPANIES PROFILED:

KEY INDUSTRY DEVELOPMENTS:

  • July 2025: Clinisys, Inc. acquired Orchard Software from Francisco Partners, an investment firm. This was aimed to strengthen the lab informatics market presence.
  • January 2025: Sapio Sciences released Sapio Lab Informatics Platform (Release 24.12) with enhanced capabilities for immunogenicity, chemistry, molecular biology, and GMP.
  • August 2024: LabWare Inc. and METTLER TOLEDO signed a collaboration agreement to boost laboratory productivity through new plug-and-play software integration.
  • December 2023: LabWare and Korber expanded their LIMS partnership to improve the overall efficiency of lab operations.
  • June 2023: STARLIMS Corporation signed a strategic partnership with INFOCOM in the Japan market.

REPORT COVERAGE

To gain extensive insights into the market, Download for Customization

Report Scope & Segmentation

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Forecast Period

2025-2032

Historical Period

2019-2023

Growth Rate

CAGR of 7.64% from 2025-2032

Unit

Value (USD Billion)

Segmentation

By Component

  • Software
  • Services

By Product

  • Laboratory Information Management Systems (LIMS)
  • Electronic Lab Notebooks (ELN)
  • Scientific Data Management Systems (SDMS)
  • Laboratory Execution Systems (LES)
  • Enterprise Content Management (ECM)
  • Others

By Deployment

  • Cloud-based
  • Web-based
  • On-premise

 By Application

  • R&D and Experiment Documentation
  • Quality Assurance/Compliance
  • Clinical Trial Data & Patient Data Management
  • Others

By End User

  • Pharmaceutical & Biotechnology Industries
  • CROs & CDMOs
  • Others

By Region

  • North America (By Component, Product, Deployment, Application, End User, and Country)
    • U.S. 
    • Canada
  • Europe (By Component, Product, Deployment, Application, End User, and Country/Sub-region)
    • Germany 
    • U.K.
    • France 
    • Spain 
    • Italy 
    • Scandinavia 
    • Rest of Europe
  • Asia Pacific (By Component, Product, Deployment, Application, End User, and Country/Sub-region)
    • China 
    • Japan 
    • India 
    • Australia 
    • Southeast Asia 
    • Rest of Asia Pacific 
  • Latin America (By Component, Product, Deployment, Application, End User, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Component, Product, Deployment, Application, End User, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa


Frequently Asked Questions

Fortune Business Insights says that the global market value stood at USD 4.11 billion in 2024 and is projected to reach USD 7.19 billion by 2032.

The market is expected to exhibit a CAGR of 7.64% during the forecast period.

The laboratory information management systems (LIMS) segment led the market by product.

The key factors driving the market include growing adoption of automation & digital transformation, and integration of AI, machine learning & analytics.

Thermo Fisher Scientific Inc., LabVantage Solutions Inc., and LabWare are some of the prominent players in the market.

North America dominated the market in 2024.

Growing R&D activities in life sciences & pharmaceuticals, and innovation in products are some of the factors that are expected to favor the product adoption.

Seeking Comprehensive Intelligence on Different Markets?Get in Touch with Our Experts Speak to an Expert
  • 2019-2032
  • 2024
  • 2019-2023
  • 185
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann